Price $129.40 |
Market Cap
5.47B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
173.3
|
P/B
5.58
|
P/S
6.05
|
Dividend %
-
|
|
P/CF
15.2
|
P/FCF
33.9
|
Op. Cash Flow
185.9K
|
FCF
3.7
|
|
Op. Margin
4.00%
|
Net Margin
3.60%
|
ROE
3.50%
|
ROI
2.70%
|
|
ROA
2.10%
|
EPS Growth
-48.50%
|
Current Ratio
3.0
|
Debt/Equity
48.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harrow Health Inc (HROW) | $7.91 | - | - | 197.7M | Strong Buy |
| Bristol-Myers Squibb Co (BMY) | $61.63 | - | 3.20% | 139.13B | Strong Buy |
| Cara Therapeutics Inc (CARA) | $18.91 | - | - | 959.8M | Strong Buy |
| RCMW Group Inc (HPTYD) | $4.00 | - | - | 14.9M | Strong Buy |
| RadNet Inc. (RDNT) | $19.41 | - | - | 969.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
